Vitamin B_{<small>12</small>}

"B12" and "Cbl" redirect here. For other uses of B12, see B12 (disambiguation). For the musical group, see Carbon Based Lifeforms.

This article is about the family of vitamins. For individual forms, see hydroxocobalamin, cyanocobalamin, methylcobalamin, and adenosylcobalamin.

Vitamin B₁₂, also known as cobalamin, is a water-soluble vitamin involved in metabolism.^[2] It is one of eight B vitamins. It is required by animals, which use it as a cofactor in DNA synthesis, in both fatty acid and amino acid metabolism.^[3] It is important in the normal functioning of the nervous system via its role in the synthesis of myelin, and in the circulatory system in the maturation of red blood cells in the bone marrow.^[2][4] Plants do not need cobalamin and carry out the reactions with enzymes that are not dependent on it.^[5]

Vitamin B₁₂
(data for cyanocobalamin)

Skeletal formula of a generic cobalamin
Stick model of cyanocobalamin (R = CN) based on the crystal structure^[1]
Clinical data
Other names	Vitamin B12, vitamin B-12, cobalamin
AHFS/Drugs.com	Monograph
MedlinePlus	a605007
License data	US DailyMed: Vitamin_b12
Routes of administration	By mouth, sublingual, intravenous (IV), intramuscular (IM), intranasal
ATC code	B03BA01 (WHO)
Legal status
Legal status	UK: POM (Prescription only) US: OTC
Pharmacokinetic data
Bioavailability	Readily absorbed in distal half of the ileum.
Protein binding	Very high to specific transcobalamins plasma proteins. Binding of hydroxocobalamin is slightly higher than cyanocobalamin.
Metabolism	liver
Elimination half-life	Approximately 6 days (400 days in the liver).
Excretion	kidney
Identifiers
IUPAC name α-(5,6-Dimethylbenzimidazolyl)cobamidcyanide
CAS Number	68-19-9^Y
PubChem CID	184933
DrugBank	DB00115^Y
ChemSpider	10469504^Y
UNII	P6YC3EG204
KEGG	D00166^Y
ChEMBL	ChEMBL2110563^Y
Chemical and physical data
Formula	C63H88CoN14O14P
Molar mass	1355.388 g·mol^−1
3D model (JSmol)	Interactive image
SMILES NC(=O)C[C@@]8(C)[C@H](CCC(N)=O)C=2/N=C8/C(/C)=C1/[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@](C)(N1[Co+]C#N)[C@@H]7/N=C(C(\C)=C3/N=C(/C=2)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NCC(C)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@H](n5cnc4cc(C)c(C)cc45)[C@@H]6O)[C@H]7CC(N)=O
InChI InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72–42)32(4)54(59)73–56;1–2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;;+2/p-2/t31?,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1^Y Key:RMRCNWBMXRMIRW-WYVZQNDMSA-L^Y

Vitamin B₁₂ is the most chemically complex of all vitamins,^[6] and for humans, the only vitamin that must be sourced from animal-derived foods or from supplements.^[2][7] Only some archaea and bacteria can synthesize vitamin B₁₂.^[8] Most people in developed countries get enough B₁₂ from the consumption of meat or foods with animal sources.^[2] Foods containing vitamin B₁₂ include meat, clams, liver, fish, poultry, eggs, and dairy products.^[2] Many breakfast cereals are fortified with the vitamin.^[2] Supplements and medications are available to treat and prevent vitamin B₁₂ deficiency.^[2] They are taken by mouth, but for the treatment of deficiency may also be given as an intramuscular injection.^[2][6]

The most common cause of vitamin B₁₂ deficiency in developed countries is impaired absorption due to a loss of gastric intrinsic factor (IF) which must be bound to a food-source of B₁₂ in order for absorption to occur.^[9] A second major cause is age-related decline in stomach acid production (achlorhydria), because acid exposure frees protein-bound vitamin.^[10] For the same reason, people on long-term antacid therapy, using proton-pump inhibitors, H₂ blockers or other antacids are at increased risk.^[11] The diets of vegetarians and vegans may not provide sufficient B₁₂ unless a dietary supplement is consumed. A deficiency in vitamin B₁₂ may be characterized by limb neuropathy or a blood disorder called pernicious anemia, a type of megaloblastic anemia, causing a feeling of tiredness and weakness, lightheadedness, headache, breathlessness, loss of appetite, abnormal sensations, changes in mobility, severe joint pain, muscle weakness, memory problems, decreased level of consciousness, brain fog, and many others.^[12] If left untreated in infants, deficiency may lead to neurological damage and anemia.^[2] Folate levels in the individual may affect the course of pathological changes and symptomatology of vitamin B₁₂ deficiency.

Vitamin B₁₂ was discovered as a result of pernicious anemia, an autoimmune disorder in which the blood has a lower than normal number of red blood cells, due to a deficiency in vitamin B₁₂.^[5][13] The ability to absorb the vitamin declines with age, especially in people over 60 years old.^[14]

Definition

Vitamin B₁₂ is a coordination complex of cobalt, which occupies the center of a corrin ligand and is further bound to a benzimidazole ligand and adenosyl group.^[15] It is a deep red solid that dissolves in water to give red solutions.

A number of related species are known and these behave similarly, in particular all function as vitamins. This collection of compounds, of which vitamin B₁₂ is one member, are often referred to as "cobalamins". These chemical compounds have a similar molecular structure, each of which shows vitamin activity in a vitamin-deficient biological system, they are referred to as vitamers. The vitamin activity is as a coenzyme, meaning that its presence is required for some enzyme-catalyzed reactions.^[10][16]

• adenosylcobalamin
• cyanocobalamin, the adenosyl ligand in vitamin B₁₂ is replaced by cyanide.
• hydroxocobalamin, the adenosyl ligand in vitamin B₁₂ is replaced by hydroxide.
• methylcobalamin, the adenosyl ligand in vitamin B₁₂ is replaced by methyl.

Cyanocobalamin is a manufactured form of B₁₂. Bacterial fermentation creates AdoB₁₂ and MeB₁₂, which are converted to cyanocobalamin by addition of potassium cyanide in the presence of sodium nitrite and heat. Once consumed, cyanocobalamin is converted to the biologically active AdoB₁₂ and MeB₁₂. The two bioactive forms of vitamin B
₁₂ are methylcobalamin in cytosol and adenosylcobalamin in mitochondria.

Cyanocobalamin is the most common form used in dietary supplements and food fortification because cyanide stabilizes the molecule against degradation. Methylcobalamin is also offered as a dietary supplement.^[10] There is no advantage to the use of adenosylcobalamin or methylcobalamin for treatment of vitamin B₁₂ deficiency.^[17][18][4]

Hydroxocobalamin can be injected intramuscularly to treat vitamin B₁₂ deficiency. It can also be injected intravenously for the purpose of treating cyanide poisoning, as the hydroxyl group is displaced by cyanide, creating a non-toxic cyanocobalamin that is excreted in urine.

"Pseudovitamin B₁₂" refers to compounds that are corrinoids with a structure similar to the vitamin but without vitamin activity.^[19] Pseudovitamin B₁₂ is the majority corrinoid in spirulina, an algal health food sometimes erroneously claimed as having this vitamin activity.^[20]

Deficiency

Main article: Vitamin B₁₂ deficiency

Vitamin B₁₂ deficiency can potentially cause severe and irreversible damage, especially to the brain and nervous system.^[6][21] At levels only slightly lower than normal, a range of symptoms such as feeling tired, weak, feeling like one may faint, dizziness, breathlessness, headaches, mouth ulcers, upset stomach, decreased appetite, difficulty walking (staggering balance problems),^[12][22] muscle weakness, depression, poor memory, poor reflexes, confusion, and pale skin, feeling abnormal sensations, among others, may be experienced, especially in people over age 60.^[6][12][23] Vitamin B₁₂ deficiency can also cause symptoms of mania and psychosis.^[24][25] Among other problems, weakened immunity, reduced fertility and interruption of blood circulation in women may occur.^[26]

The main type of vitamin B12 deficiency anemia is pernicious anemia.^[27] It is characterized by a triad of symptoms:

1. Anemia with bone marrow promegaloblastosis (megaloblastic anemia). This is due to the inhibition of DNA synthesis (specifically purines and thymidine).
2. Gastrointestinal symptoms: alteration in bowel motility, such as mild diarrhea or constipation, and loss of bladder or bowel control.^[28] These are thought to be due to defective DNA synthesis inhibiting replication in tissue sites with a high turnover of cells. This may also be due to the autoimmune attack on the parietal cells of the stomach in pernicious anemia. There is an association with gastric antral vascular ectasia (which can be referred to as watermelon stomach), and pernicious anemia.^[29]
3. Neurological symptoms: sensory or motor deficiencies (absent reflexes, diminished vibration or soft touch sensation) and subacute combined degeneration of the spinal cord.^[30] Deficiency symptoms in children include developmental delay, regression, irritability, involuntary movements and hypotonia.^[31]

Vitamin B₁₂ deficiency is most commonly caused by malabsorption, but can also result from low intake, immune gastritis, low presence of binding proteins, or use of certain medications.^[6] Vegans—people who choose to not consume any animal-sourced foods—are at risk because plant-sourced foods do not contain the vitamin in sufficient amounts to prevent vitamin deficiency.^[32] Vegetarians—people who consume animal byproducts such as dairy products and eggs, but not the flesh of any animal—are also at risk. Vitamin B₁₂ deficiency has been observed in between 40% and 80% of the vegetarian population who do not also take a vitamin B₁₂ supplement or consume vitamin-fortified food.^[33] In Hong Kong and India, vitamin B₁₂ deficiency has been found in roughly 80% of the vegan population. As with vegetarians, vegans can avoid this by consuming a dietary supplement or eating B₁₂ fortified food such as cereal, plant-based milks, and nutritional yeast as a regular part of their diet.^[34] The elderly are at increased risk because they tend to produce less stomach acid as they age, a condition known as achlorhydria, thereby increasing their probability of B₁₂ deficiency due to reduced absorption.^[2]

Pregnancy, lactation and early childhood

The U.S. Recommended Dietary Allowance (RDA) for pregnancy is 2.6 µg/day, for lactation 2.8 µg/day. Determination of these values was based on the RDA of 2.4 µg/day for non-pregnant women plus what will be transferred to the fetus during pregnancy and what will be delivered in breast milk.^{[10][35]: 972} However, looking at the same scientific evidence, the European Food Safety Authority (EFSA) sets adequate intake (AI) at 4.5 μg/day for pregnancy and 5.0 μg/day for lactation.^[36] Low maternal vitamin B₁₂, defined as serum concentration less than 148 pmol/L, increases the risk of miscarriage, preterm birth and newborn low birth weight.^[37][35] During pregnancy the placenta concentrates B₁₂, so that newborn infants have a higher serum concentration than their mothers.^[10] As it is recently absorbed vitamin content that more effectively reaches the placenta, the vitamin consumed by the mother-to-be is more important than that contained in her liver tissue.^[10][38] Women who consume little animal-sourced food, or who are vegetarian or vegan, are at higher risk of becoming vitamin depleted during pregnancy than those who consume more animal products. This depletion can lead to anemia, and also an increased risk that their breastfed infants become vitamin deficient.^[38][35]

Low vitamin concentrations in human milk occur in families with low socioeconomic status or low consumption of animal products.^{[35]: 971, 973} Only a few countries, primarily in Africa, have mandatory food fortification programs for either wheat flour or maize flour; India has a voluntary fortification program.^[39] What the nursing mother consumes is more important than her liver tissue content, as it is recently absorbed vitamin that more effectively reaches breast milk.^[35]: 973 Breast milk B₁₂ decreases over months of nursing in both well-nourished and vitamin-deficient mothers.^{[35]: 973–974} Exclusive or near-exclusive breastfeeding beyond six months is a strong indicator of low serum vitamin status in nursing infants. This is especially true when the vitamin status was poor during the pregnancy and if the early-introduced foods fed to the still breastfeeding infant are vegan.^{[35]: 974–975} Risk of deficiency persists if the post-weaning diet is low in animal products.^{[35]: 974–975} Signs of low vitamin levels in infants and young children can include anemia, poor physical growth and neurodevelopmental delays.^[35]: 975 Children diagnosed with low serum B₁₂ can be treated with intramuscular injections, then transitioned to an oral dietary supplement.^[35]: 976

Gastric bypass surgery

Various methods of gastric bypass or gastric restriction surgery are used to treat morbid obesity. Roux-en-Y gastric bypass surgery (RYGB) but not sleeve gastric bypass surgery or gastric banding, increases the risk of vitamin B₁₂ deficiency and requires preventive post-operative treatment with either injected or high-dose oral supplementation.^[40][41][42] For post-operative oral supplementation, 1000 μg/day may be needed to prevent vitamin deficiency.^[42]

Diagnosis

According to one review: "At present, no 'gold standard' test exists for the diagnosis of vitamin B₁₂ deficiency and as a consequence the diagnosis requires consideration of both the clinical state of the patient and the results of investigations."^[43] The vitamin deficiency is typically suspected when a routine complete blood count shows anemia with an elevated mean corpuscular volume (MCV). In addition, on the peripheral blood smear, macrocytes and hypersegmented polymorphonuclear leukocytes may be seen. Diagnosis is supported based on vitamin B₁₂ blood levels below 150–180 pmol/L (200–250 pg/mL) in adults. However, serum values can be maintained while tissue B₁₂ stores are becoming depleted. Therefore, serum B₁₂ values above the cut-off point of deficiency do not necessarily confirm adequate B₁₂ status.^[2] For this reason, elevated serum homocysteine over 15 micromol/L and methylmalonic acid (MMA) over 0.271 micromol/L are considered better indicators of B₁₂ deficiency, rather than relying only on the concentration of B₁₂ in blood.^[2] However, elevated MMA is not conclusive, as it is seen in people with B₁₂ deficiency, but also in elderly people who have renal insufficiency,^[25] and elevated homocysteine is not conclusive, as it is also seen in people with folate deficiency.^[44] In addition, elevated methylmalonic acid levels may also be related to metabolic disorders such as methylmalonic acidemia.^[45] If nervous system damage is present and blood testing is inconclusive, a lumbar puncture may be carried out to measure cerebrospinal fluid B₁₂ levels.^[46]

Medical uses

 

A vitamin B₁₂ solution (hydroxocobalamin) in a multi-dose bottle, with a single dose drawn up into a syringe for injection. Preparations are usually bright red.

Repletion of deficiency

Severe vitamin B₁₂ deficiency is corrected with frequent intramuscular injections of large doses of the vitamin, followed by maintenance doses of injections or oral dosing at longer intervals. In the UK, standard initial therapy consists of intramuscular injections of 1000 μg of hydroxocobalamin three times a week for two weeks or until neurological symptoms improve, followed by 1000 μg every two or three months.^[47] Injection side effects include skin rash, itching, chills, fever, hot flushes, nausea and dizziness.^[47]

Cyanide poisoning

For cyanide poisoning, a large amount of hydroxocobalamin may be given intravenously and sometimes in combination with sodium thiosulfate.^[48][49] The mechanism of action is straightforward: the hydroxycobalamin hydroxide ligand is displaced by the toxic cyanide ion, and the resulting non-toxic cyanocobalamin is excreted in urine.^[50]

Dietary recommendations

Most people in the United States and the United Kingdom consume sufficient vitamin B₁₂.^[2][9] However, proportions of people with low or marginal levels of vitamin B₁₂ reach up to 40% in the Western world.^[2] Grain-based foods can be fortified by having the vitamin added to them. Vitamin B₁₂ supplements are available as single or multivitamin tablets. Pharmaceutical preparations of vitamin B₁₂ may be given by intramuscular injection.^[6][51] Since there are few non-animal sources of the vitamin, vegans are advised to consume a dietary supplement or fortified foods for B₁₂ intake, or risk serious health consequences.^[6] Children in some regions of developing countries are at particular risk due to increased requirements during growth coupled with diets low in animal-sourced foods.

The US National Academy of Medicine updated estimated average requirements (EARs) and recommended dietary allowances (RDAs) for vitamin B₁₂ in 1998.^[6] The EAR for vitamin B₁₂ for women and men ages 14 and up is 2.0 μg/day; the RDA is 2.4 μg/day. RDA is higher than EAR so as to identify amounts that will cover people with higher than average requirements. RDA for pregnancy equals 2.6 μg/day. RDA for lactation equals 2.8 μg/day. For infants up to 12 months the adequate intake (AI) is 0.4–0.5 μg/day. (AIs are established when there is insufficient information to determine EARs and RDAs.) For children ages 1–13 years the RDA increases with age from 0.9 to 1.8 μg/day. Because 10 to 30 percent of older people may be unable to effectively absorb vitamin B₁₂ naturally occurring in foods, it is advisable for those older than 50 years to meet their RDA mainly by consuming foods fortified with vitamin B₁₂ or a supplement containing vitamin B₁₂. As for safety, tolerable upper intake levels (known as ULs) are set for vitamins and minerals when evidence is sufficient. In the case of vitamin B₁₂ there is no UL, as there is no human data for adverse effects from high doses. Collectively the EARs, RDAs, AIs and ULs are referred to as dietary reference intakes (DRIs).^[10]

The European Food Safety Authority (EFSA) refers to the collective set of information as "dietary reference values", with population reference intake (PRI) instead of RDA, and average requirement instead of EAR. AI and UL are defined by EFSA the same as in the United States. For women and men over age 18 the adequate intake (AI) is set at 4.0 μg/day. AI for pregnancy is 4.5 μg/day, for lactation 5.0 μg/day. For children aged 1–17 years the AIs increase with age from 1.5 to 3.5 μg/day. These AIs are higher than the U.S. RDAs.^[36] The EFSA also reviewed the safety question and reached the same conclusion as in the United States—that there was not sufficient evidence to set a UL for vitamin B₁₂.^[52]

The Japan National Institute of Health and Nutrition set the RDA for people ages 12 and older at 2.4 μg/day.^[53] The World Health Organization also uses 2.4 μg/day as the adult recommended nutrient intake for this vitamin.^[54]

For U.S. food and dietary supplement labeling purposes the amount in a serving is expressed as a "percent of daily value" (%DV). For vitamin B₁₂ labeling purposes 100% of the daily value was 6.0 μg, but on May 27, 2016, it was revised downward to 2.4 μg.^[55][56] Compliance with the updated labeling regulations was required by 1 January 2020 for manufacturers with US$10 million or more in annual food sales, and by 1 January 2021 for manufacturers with lower volume food sales.^[57][58] A table of the old and new adult daily values is provided at Reference Daily Intake.

Sources

Bacteria and archaea

Vitamin B₁₂ is produced in nature by certain bacteria, and archaea.^[59][60][61] It is synthesized by some bacteria in the gut microbiota in humans and other animals, but it has long been thought that humans cannot absorb this as it is made in the colon, downstream from the small intestine, where the absorption of most nutrients occurs.^[62] Ruminants, such as cows and sheep, are foregut fermenters, meaning that plant food undergoes microbial fermentation in the rumen before entering the true stomach (abomasum), and thus they are absorbing vitamin B₁₂ produced by bacteria.^[62][63] Other mammalian species (examples: rabbits, pikas, beaver, guinea pigs) consume high-fibre plants which pass through the intestinal system and undergo bacterial fermentation in the cecum and large intestine. The first-passage of feces produced by this hindgut fermentation, called "cecotropes", are re-ingested, a practice referred to as cecotrophy or coprophagy. Re-ingestion allows for absorption of nutrients made available by bacterial digestion, and also of vitamins and other nutrients synthesized by the gut bacteria, including vitamin B₁₂.^[63] Non-ruminant, non-hindgut herbivores may have an enlarged forestomach and/or small intestine to provide a place for bacterial fermentation and B-vitamin production, including B₁₂.^[63] For gut bacteria to produce vitamin B₁₂ the animal must consume sufficient amounts of cobalt.^[64] Soil that is deficient in cobalt may result in B₁₂ deficiency, and B₁₂ injections or cobalt supplementation may be required for livestock.^[65]

Animal-derived foods

Animals store vitamin B₁₂ from their diets in their livers and muscles and some pass the vitamin into their eggs and milk. Meat, liver, eggs and milk are therefore sources of the vitamin for other animals, including humans.^[51][2][66] For humans, the bioavailability from eggs is less than 9%, compared to 40% to 60% from fish, fowl and meat.^[67] Insects are a source of B₁₂ for animals (including other insects and humans).^[66][68] Animal-derived food sources with a high concentration of vitamin B₁₂ include liver and other organ meats from lamb, veal, beef, and turkey; also shellfish and crab meat.^[6][51][69]

Plants and algae

Natural plant and algae sources of vitamin B₁₂ include fermented plant foods such as tempeh^[70][71][72] and seaweed-derived foods such as nori and laver.^[73][74][75] Other types of algae are rich in B₁₂, with some species, such as Porphyra yezoensis,^[73] containing as much cobalamin as liver.^[76] Methylcobalamin has been identified in Chlorella vulgaris.^[77] Since only bacteria and some archea possess the genes and enzymes necessary to synthesize vitamin B₁₂, plant and algae sources all obtain the vitamin secondarily from symbiosis with various species of bacteria,^[5] or in the case of fermented plant foods, from bacterial fermentation.^[70][71]

The Academy of Nutrition and Dietetics considers plant and algae sources "unreliable", stating that vegans should turn to fortified foods and supplements instead.^[32]

Fortified foods

Foods for which vitamin B₁₂-fortified versions are available include breakfast cereals, plant-derived milk substitutes such as soy milk and oat milk, energy bars, and nutritional yeast.^[69] The fortification ingredient is cyanocobalamin. Microbial fermentation yields adenosylcobalamin, which is then converted to cyanocobalamin by addition of potassium cyanide or thiocyanate in the presence of sodium nitrite and heat.^[78]

As of 2019, nineteen countries require food fortification of wheat flour, maize flour or rice with vitamin B₁₂. Most of these are in southeast Africa or Central America.^[39]

Vegan advocacy organizations, among others, recommend that every vegan consume B₁₂ from either fortified foods or supplements.^{[6][34][79][80]}

Supplements

 

A blister pack of 500 µg methylcobalamin tablets

Vitamin B₁₂ is included in multivitamin pills; in some countries grain-based foods such as bread and pasta are fortified with B₁₂. In the US, non-prescription products can be purchased providing up to 5,000 µg each, and it is a common ingredient in energy drinks and energy shots, usually at many times the recommended dietary allowance of B₁₂. The vitamin can also be a prescription product via injection or other means.^[2]

Sublingual methylcobalamin, which contains no cyanide, is available in 5 mg tablets. The metabolic fate and biological distribution of methylcobalamin are expected to be similar to that of other sources of vitamin B₁₂ in the diet.^[81] The amount of cyanide in cyanocobalamin is generally not a concern, even in the 1,000 µg dose, since the amount of cyanide there (20 µg in a 1,000 µg cyanocobalamin tablet) is less than the daily consumption of cyanide from food, and therefore cyanocobalamin is not considered a health risk.^[81] People who have kidney problems should not take large doses of cyanocobalamin due to their inability to efficiently metabolize cyanide.^[82]

Intramuscular or intravenous injection

Injection of hydroxycobalamin is often used if digestive absorption is impaired,^[2] but this course of action may not be necessary with high-dose oral supplements (such as 0.5–1.0 mg or more),^[83][84] because with large quantities of the vitamin taken orally, even the 1% to 5% of free crystalline B₁₂ that is absorbed along the entire intestine by passive diffusion may be sufficient to provide a necessary amount.^[85]

A person with cobalamin C disease (which results in combined methylmalonic aciduria and homocystinuria) may require treatment with intravenous or intramuscular hydroxocobalamin or transdermal B₁₂, because oral cyanocobalamin is inadequate in the treatment of cobalamin C disease.^[86]

Nanotechnologies used in vitamin B₁₂ supplementation

Conventional administration does not ensure specific distribution and controlled release of vitamin B₁₂. Moreover, therapeutic protocols involving injection require health care people and commuting of patients to the hospital thus increasing the cost of the treatment and impairing the lifestyle of patients. Targeted delivery of vitamin B₁₂ is a major focus of modern prescriptions. For example, conveying the vitamin to the bone marrow and nerve cells would help myelin recovery. Currently, several nanocarriers strategies are being developed for improving vitamin B₁₂ delivery with the aim to simplify administration, reduce costs, improve pharmacokinetics, and ameliorate the quality of patients' lives.^[87]

Pseudovitamin-B₁₂

Pseudovitamin-B₁₂ refers to B₁₂-like analogues that are biologically inactive in humans.^[19] Most cyanobacteria, including Spirulina, and some algae, such as Porphyra tenera (used to make a dried seaweed food called nori in Japan), have been found to contain mostly pseudovitamin-B₁₂ instead of biologically active B₁₂.^[20][88] These pseudo-vitamin compounds can be found in some types of shellfish,^[19] in edible insects,^[89] and at times as metabolic breakdown products of cyanocobalamin added to dietary supplements and fortified foods.^[90]

Pseudovitamin-B₁₂ can show up as biologically active vitamin B₁₂ when a microbiological assay with Lactobacillus delbrueckii subsp. lactis is used, as the bacteria can utilize the pseudovitamin despite it being unavailable to humans. To get a reliable reading of B₁₂ content, more advanced techniques are available. One such technique involves pre-separation by silica gel and then assessment with B₁₂-dependent E. coli bacteria.^[19]

A related concept is antivitamin B₁₂, compounds (often synthetic B₁₂ analogues) that not only have no vitamin action, but also actively interfere with the activity of true vitamin B₁₂. The design of these compounds mainly involved replacement of the metal ion. These compounds have the potential to be used for analyzing B₁₂ utilization pathways or even attacking B₁₂-dependent pathogens.^[91]

Drug interactions

H₂-receptor antagonists and proton-pump inhibitors

Gastric acid is needed to release vitamin B₁₂ from protein for absorption. Reduced secretion of gastric acid and pepsin, from the use of H₂ blocker or proton-pump inhibitor (PPI) drugs, can reduce absorption of protein-bound (dietary) vitamin B₁₂, although not of supplemental vitamin B₁₂. H₂-receptor antagonist examples include cimetidine, famotidine, nizatidine, and ranitidine. PPIs examples include omeprazole, lansoprazole, rabeprazole, pantoprazole, and esomeprazole. Clinically significant vitamin B₁₂ deficiency and megaloblastic anemia are unlikely, unless these drug therapies are prolonged for two or more years, or if in addition the person's dietary intake is below recommended levels. Symptomatic vitamin deficiency is more likely if the person is rendered achlorhydric (a complete absence of gastric acid secretion), which occurs more frequently with proton pump inhibitors than H₂ blockers.^[92]

Metformin

Reduced serum levels of vitamin B₁₂ occur in up to 30% of people taking long-term anti-diabetic metformin.^[93][94] Deficiency does not develop if dietary intake of vitamin B₁₂ is adequate or prophylactic B₁₂ supplementation is given. If the deficiency is detected, metformin can be continued while the deficiency is corrected with B₁₂ supplements.^[95]

Other drugs

Certain medications can decrease the absorption of orally consumed vitamin B₁₂, including: colchicine, extended-release potassium products, and antibiotics such as gentamicin, neomycin and tobramycin.^[96] Anti-seizure medications phenobarbital, pregabalin, primidone and topiramate are associated with lower than normal serum vitamin concentration. However, serum levels were higher in people prescribed valproate.^[97] In addition, certain drugs may interfere with laboratory tests for the vitamin, such as amoxicillin, erythromycin, methotrexate and pyrimethamine.^[96]

Chemistry

 

Methylcobalamin (shown) is a form of vitamin B₁₂. Physically it resembles the other forms of vitamin B₁₂, occurring as dark red crystals that freely form cherry-colored transparent solutions in water.

Vitamin B₁₂ is the most chemically complex of all the vitamins.^[6] The structure of B₁₂ is based on a corrin ring, which is similar to the porphyrin ring found in heme. The central metal ion is cobalt. As isolated as an air-stable solid and available commercially, cobalt in vitamin B₁₂ (cyanocobalamin and other vitamers) is present in its +3 oxidation state. Biochemically, the cobalt center can take part in both two-electron and one-electron reductive processes to access the "reduced" (B_12r, +2 oxidation state) and "super-reduced" (B_12s, +1 oxidation state) forms. The ability to shuttle between the +1, +2, and +3 oxidation states is responsible for the versatile chemistry of vitamin B₁₂, allowing it to serve as a donor of deoxyadenosyl radical (radical alkyl source) and as a methyl cation equivalent (electrophilic alkyl source).^[98] Four of the six coordination sites are provided by the corrin ring, and a fifth by a dimethylbenzimidazole group. The sixth coordination site, the reactive center, is variable, being a cyano group (–CN), a hydroxyl group (–OH), a methyl group (–CH₃) or a 5′-deoxyadenosyl group. Historically, the covalent carbon–cobalt bond is one of the first examples of carbon–metal bonds to be discovered in biology. The hydrogenases and, by necessity, enzymes associated with cobalt utilization, involve metal–carbon bonds.^[99] Animals have the ability to convert cyanocobalamin and hydroxocobalamin to the bioactive forms adenosylcobalamin and methylcobalamin by means of enzymatically replacing the cyano or hydroxyl groups.

 

The structures of the four most common vitamers of cobalamin, together with some synonyms. The structure of the 5'-deoxyadenosyl group, which forms the R group of adenosylcobalamin is also shown.

Methods for the analysis of vitamin B₁₂ in food

Several methods have been used to determine the vitamin B₁₂ content in foods including microbiological assays, chemiluminescence assays, polarographic, spectrophotometric and high-performance liquid chromatography processes.^[100] The microbiological assay has been the most commonly used assay technique for foods, utilizing certain vitamin B₁₂-requiring microorganisms, such as Lactobacillus delbrueckii subsp. lactis ATCC7830.^[67] However, it is no longer the reference method due to the high measurement uncertainty of vitamin B₁₂.^[101] Furthermore, this assay requires overnight incubation and may give false results if any inactive vitamin B₁₂ analogues are present in the foods.^[102] Currently, radioisotope dilution assay (RIDA) with labelled vitamin B₁₂ and hog IF (pigs) have been used to determine vitamin B₁₂ content in food.^[67] Previous reports have suggested that the RIDA method is able to detect higher concentrations of vitamin B₁₂ in foods compared to the microbiological assay method.^[67][100]

Biochemistry

Coenzyme function

Vitamin B₁₂ functions as a coenzyme, meaning that its presence is required in some enzyme-catalyzed reactions.^[10][16] Listed here are the three classes of enzymes that sometimes require B₁₂ to function (in animals):

1. Isomerases

   Rearrangements in which a hydrogen atom is directly transferred between two adjacent atoms with concomitant exchange of the second substituent, X, which may be a carbon atom with substituents, an oxygen atom of an alcohol, or an amine. These use the adoB₁₂ (adenosylcobalamin) form of the vitamin.^[103]

2. Methyltransferases

   Methyl (–CH₃) group transfers between two molecules. These use the MeB₁₂ (methylcobalamin) form of the vitamin.^[104]

3. Dehalogenases

   Some species of anaerobic bacteria synthesize B₁₂-dependent dehalogenases, which have potential commercial applications for degrading chlorinated pollutants. The microorganisms may either be capable of de novo corrinoid biosynthesis or are dependent on exogenous vitamin B₁₂.^[105][106]

In humans, two major coenzyme B₁₂-dependent enzyme families corresponding to the first two reaction types, are known. These are typified by the following two enzymes:

 

Simplified schematic diagram of the folate methionine cycle. Methionine synthase transfers the methyl group to the vitamin and then transfers the methyl group to homocysteine, converting that to methionine.

Methylmalonyl coenzyme A mutase (MUT) is an isomerase enzyme which uses the AdoB₁₂ form and reaction type 1 to convert L-methylmalonyl-CoA to succinyl-CoA, an important step in the catabolic breakdown of some amino acids into succinyl-CoA, which then enters energy production via the citric acid cycle.^[103] This functionality is lost in vitamin B₁₂ deficiency, and can be measured clinically as an increased serum methylmalonic acid (MMA) concentration. The MUT function is necessary for proper myelin synthesis.^[4] Based on animal research, it is thought that the increased methylmalonyl-CoA hydrolyzes to form methylmalonate (methylmalonic acid), a neurotoxic dicarboxylic acid, causing neurological deterioration.^[107]

Methionine synthase, coded by MTR gene, is a methyltransferase enzyme which uses the MeB₁₂ and reaction type 2 to transfer a methyl group from 5-methyltetrahydrofolate to homocysteine, thereby generating tetrahydrofolate (THF) and methionine.^[104] This functionality is lost in vitamin B₁₂ deficiency, resulting in an increased homocysteine level and the trapping of folate as 5-methyl-tetrahydrofolate, from which THF (the active form of folate) cannot be recovered. THF plays an important role in DNA synthesis so reduced availability of THF results in ineffective production of cells with rapid turnover, in particular red blood cells, and also intestinal wall cells which are responsible for absorption. THF may be regenerated via MTR or may be obtained from fresh folate in the diet. Thus all of the DNA synthetic effects of B₁₂ deficiency, including the megaloblastic anemia of pernicious anemia, resolve if sufficient dietary folate is present. Thus the best-known "function" of B₁₂ (that which is involved with DNA synthesis, cell-division, and anemia) is actually a facultative function which is mediated by B₁₂-conservation of an active form of folate which is needed for efficient DNA production.^[104] Other cobalamin-requiring methyltransferase enzymes are also known in bacteria, such as Me-H₄-MPT, coenzyme M methyltransferase.^[108]

Physiology

Absorption

Food B₁₂ is absorbed by two processes. The first is a vitamin B₁₂-specific intestinal mechanism using intrinsic factor through which 1–2 micrograms can be absorbed every few hours, by which most food consumption of the vitamin is absorbed. The second is a passive diffusion process.^[10] The human physiology of active vitamin B₁₂ absorption from food is complex. Protein-bound vitamin B₁₂ must be released from the proteins by the action of digestive proteases in both the stomach and small intestine. Gastric acid releases the vitamin from food particles; therefore antacid and acid-blocking medications (especially proton-pump inhibitors) may inhibit absorption of B₁₂. After B₁₂ has been freed from proteins in food by pepsin in the stomach, R-protein (also known as haptocorrin and transcobalamin-1), a B₁₂ binding protein that is produced in the salivary glands, binds to B₁₂. This protects the vitamin from degradation in the acidic environment of the stomach.^[109] This pattern of B₁₂ transfer to a special binding protein secreted in a previous digestive step, is repeated once more before absorption. The next binding protein for B₁₂ is intrinsic factor (IF), a protein synthesized by gastric parietal cells that is secreted in response to histamine, gastrin and pentagastrin, as well as the presence of food. In the duodenum, proteases digest R-proteins and release their bound B₁₂, which then binds to IF, to form a complex (IF/B₁₂). B₁₂ must be attached to IF for it to be efficiently absorbed, as receptors on the enterocytes in the terminal ileum of the small bowel only recognize the B₁₂-IF complex; in addition, intrinsic factor protects the vitamin from catabolism by intestinal bacteria.^[10]

Absorption of food vitamin B₁₂ thus requires an intact and functioning stomach, exocrine pancreas, intrinsic factor, and small bowel.^[10] Problems with any one of these organs makes a vitamin B₁₂ deficiency possible. Individuals who lack intrinsic factor have a decreased ability to absorb B₁₂. In pernicious anemia, there is a lack of IF due to autoimmune atrophic gastritis, in which antibodies form against parietal cells. Antibodies may alternately form against and bind to IF, inhibiting it from carrying out its B₁₂ protective function. Due to the complexity of B₁₂ absorption, geriatric patients, many of whom are hypoacidic due to reduced parietal cell function, have an increased risk of B₁₂ deficiency.^[110] This results in 80–100% excretion of oral doses in the feces versus 30–60% excretion in feces as seen in individuals with adequate IF.^[110]

Once the IF/B₁₂ complex is recognized by specialized ileal receptors, it is transported into the portal circulation. The vitamin is then transferred to transcobalamin II (TC-II/B₁₂), which serves as the plasma transporter. Hereditary defects in production of the transcobalamins and their receptors may produce functional deficiencies in B₁₂ and infantile megaloblastic anemia, and abnormal B₁₂ related biochemistry, even in some cases with normal blood B₁₂ levels. For the vitamin to serve inside cells, the TC-II/B₁₂ complex must bind to a cell receptor, and be endocytosed. The transcobalamin II is degraded within a lysosome, and free B₁₂ is finally released into the cytoplasm, where it may be transformed into the proper coenzyme, by certain cellular enzymes (see above).^[10][111]

Investigations into the intestinal absorption of B₁₂ point out that the upper limit of absorption per single oral dose, under normal conditions, is about 1.5 µg. The passive diffusion process of B₁₂ absorption—normally a very small portion of total absorption of the vitamin from food consumption^[10]—may exceed the R-protein and IF mediated absorption when oral doses of B₁₂ are very large (a thousand or more µg per dose) as commonly happens in dedicated-pill oral B₁₂ supplementation. This allows pernicious anemia and certain other defects in B₁₂ absorption to be treated with oral megadoses of B₁₂, even without any correction of the underlying absorption defects.^[112] See the section on supplements above.

Storage and excretion

How fast B₁₂ levels change depends on the balance between how much B₁₂ is obtained from the diet, how much is secreted and how much is absorbed. The total amount of vitamin B₁₂ stored in the body is about 2–5 mg in adults. Around 50% of this is stored in the liver. Approximately 0.1% of this is lost per day by secretions into the gut, as not all these secretions are reabsorbed. Bile is the main form of B₁₂ excretion; most of the B₁₂ secreted in the bile is recycled via enterohepatic circulation. Excess B₁₂ beyond the blood's binding capacity is typically excreted in urine. Owing to the extremely efficient enterohepatic circulation of B₁₂, the liver can store 3 to 5 years' worth of vitamin B₁₂; therefore, nutritional deficiency of this vitamin is rare in adults in the absence of malabsorption disorders.^[10] In the absence of enterohepatic reabsorption, only months to a year of vitamin B₁₂ are stored.^[113]

Synthesis

Biosynthesis

Main article: Cobalamin biosynthesis

Vitamin B₁₂ is derived from a tetrapyrrolic structural framework created by the enzymes deaminase and cosynthetase which transform aminolevulinic acid via porphobilinogen and hydroxymethylbilane to uroporphyrinogen III. The latter is the first macrocyclic intermediate common to heme, chlorophyll, siroheme and B₁₂ itself.^[114][115] Later steps, especially the incorporation of the additional methyl groups of its structure, were investigated using ¹³C methyl-labelled S-adenosyl methionine. It was not until a genetically engineered strain of Pseudomonas denitrificans was used, in which eight of the genes involved in the biosynthesis of the vitamin had been overexpressed, that the complete sequence of methylation and other steps could be determined, thus fully establishing all the intermediates in the pathway.^[116][117]

Species from the following genera and the following individual species are known to synthesize B₁₂: Propionibacterium shermanii, Pseudomonas denitrificans, Streptomyces griseus, Acetobacterium, Aerobacter, Agrobacterium, Alcaligenes, Azotobacter, Bacillus, Clostridium, Corynebacterium, Flavobacterium, Lactobacillus, Micromonospora, Mycobacterium, Nocardia, Proteus, Rhizobium, Salmonella, Serratia, Streptococcus and Xanthomonas.^[118][119]

Industrial

Industrial production of B₁₂ is achieved through fermentation of selected microorganisms.^[120] Streptomyces griseus, a bacterium once thought to be a fungus, was the commercial source of vitamin B₁₂ for many years.^[121] The species Pseudomonas denitrificans and Propionibacterium freudenreichii subsp. shermanii are more commonly used today.^[120] These are grown under special conditions to enhance yield. Rhone-Poulenc improved yield via genetic engineering P. denitrificans.^[122] Propionibacterium, the other commonly used bacteria, produce no exotoxins or endotoxins and are generally recognized as safe (have been granted GRAS status) by the Food and Drug Administration of the United States.^[123]

The total world production of vitamin B₁₂ in 2008 was 35,000 kg (77,175 lb).^[124]

Laboratory

Main article: Vitamin B₁₂ total synthesis

The complete laboratory synthesis of B₁₂ was achieved by Robert Burns Woodward^[125] and Albert Eschenmoser in 1972.^[126][127] The work required the effort of 91 postdoctoral fellows (mostly at Harvard) and 12 PhD students (at ETH Zurich) from 19 nations. The synthesis constitutes a formal total synthesis, since the research groups only prepared the known intermediate cobyric acid, whose chemical conversion to vitamin B₁₂ was previously reported. This synthesis of vitamin B₁₂ is of no practical consequence due to its length, taking 72 chemical steps and giving an overall chemical yield well under 0.01%.^[128] Although there have been sporadic synthetic efforts since 1972,^[127] the Eschenmoser–Woodward synthesis remains the only completed (formal) total synthesis.

History

Further information: Vitamin § History

Descriptions of deficiency effects

Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy.^[129]

Identification of liver as an anti-anemia food

During the 1920s, George Whipple discovered that ingesting large amounts of raw liver seemed to most rapidly cure the anemia of blood loss in dogs, and hypothesized that eating liver might treat pernicious anemia.^[130] Edwin Cohn prepared a liver extract that was 50 to 100 times more potent in treating pernicious anemia than the natural liver products. William Castle demonstrated that gastric juice contained an "intrinsic factor" which when combined with meat ingestion resulted in absorption of the vitamin in this condition.^[129] In 1934, George Whipple shared the 1934 Nobel Prize in Physiology or Medicine with William P. Murphy and George Minot for discovery of an effective treatment for pernicious anemia using liver concentrate, later found to contain a large amount of vitamin B₁₂.^[129][131]

Identification of the active compound

While working at the Bureau of Dairy Industry, U.S. Department of Agriculture, Mary Shaw Shorb was assigned work on the bacterial strain Lactobacillus lactis Dorner (LLD), which was used to make yogurt and other cultured dairy products. The culture medium for LLD required liver extract. Shorb knew that the same liver extract was used to treat pernicious anemia (her father-in-law had died from the disease), and concluded that LLD could be developed as an assay method to identify the active compound. While at the University of Maryland she received a small grant from Merck, and in collaboration with Karl Folkers from that company, developed the LLD assay. This identified "LLD factor" as essential for the bacteria's growth.^[132] Shorb, Folker and Alexander R. Todd, at the University of Cambridge, used the LLD assay to extract the anti-pernicious anemia factor from liver extracts, purify it, and name it vitamin B₁₂.^[133] In 1955, Todd helped elucidate the structure of the vitamin, for which he was awarded the Nobel Prize in Chemistry in 1957. The complete chemical structure of the molecule was determined by Dorothy Hodgkin, based on crystallographic data in 1956, for which for that and other crystallographic analyses she was awarded the Nobel Prize in Chemistry in 1964.^[134][135] Hodgkin went on to decipher the structure of insulin.^[135]

Five people have been awarded Nobel Prizes for direct and indirect studies of vitamin B₁₂: George Whipple, George Minot and William Murphy (1934), Alexander R. Todd (1957), and Dorothy Hodgkin (1964).^[136]

Nobel laureates for discoveries relating to vitamin B₁₂

•  

  George Whipple

•  

  George Minot

•  

  William P. Murphy

•  

  Alexander R. Todd

•  

  Dorothy Hodgkin

Commercial production

Industrial production of vitamin B₁₂ is achieved through fermentation of selected microorganisms.^[120] As noted above, the completely synthetic laboratory synthesis of B12 was achieved by Robert Burns Woodward and Albert Eschenmoser in 1972, though this process has no commercial potential, requiring almost 70 steps and having a yield well below 0.01%.^[128]

Society and culture

In the 1970s, John A. Myers, a physician residing in Baltimore, developed a program of injecting vitamins and minerals intravenously for various medical conditions. The formula included 1000 µg of cyanocobalamin. This came to be known as the Myers' cocktail. After his death in 1984, other physicians and naturopaths took up prescribing "intravenous micro-nutrient therapy" with unsubstantiated health claims for treating fatigue, low energy, stress, anxiety, migraine, depression, immunocompromised, promoting weight loss and more.^[137] However, other than a report on case studies^[137] there are no benefits confirmed in the scientific literature.^[138] Healthcare practitioners at clinics and spas prescribe versions of these intravenous combination products, but also intramuscular injections of just vitamin B₁₂. A Mayo Clinic review concluded that there is no solid evidence that vitamin B₁₂ injections provide an energy boost or aid weight loss.^[139]

There is evidence that for elderly people, physicians often repeatedly prescribe and administer cyanocobalamin injections inappropriately, evidenced by the majority of subjects in one large study either having had normal serum concentrations or had not been tested prior to the injections.^[140]

See also

• Adenosylcobalamin
• Cobalamin biosynthesis
• Cyanocobalamin
• Hydroxocobalamin
• Methylcobalamin

• Vitamins

Further reading

• Gherasim C, Lofgren M, Banerjee R (May 2013). "Navigating the B(12) road: assimilation, delivery, and disorders of cobalamin". J. Biol. Chem. 288 (19): 13186–13193. doi:10.1074/jbc.R113.458810. PMC 3650358. PMID 23539619.

References

1. Prieto T, Neuburger M, Spingler B, Zelder F (2016). "Inorganic Cyanide as Protecting Group in the Stereospecific Reconstitution of Vitamin B₁₂ from an Artificial Green Secocorrinoid". Org. Lett. 18 (20): 5292–5295. doi:10.1021/acs.orglett.6b02611. PMID 27726382.
2. Office of Dietary Supplements (6 April 2021). "Vitamin B12: Fact Sheet for Health Professionals". Bethesda, Maryland: US National Institutes of Health. from the original on 2021-10-08. Retrieved 24 December 2021.
3. Yamada K (2013). "Cobalt: Its Role in Health and Disease". In Sigel A, Sigel H, Sigel RK (eds.). Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. Vol. 13. Springer. pp. 295–320. doi:10.1007/978-94-007-7500-8_9. ISBN 978-94-007-7499-5. PMID 24470095.
4. Calderón-Ospina CA, Nava-Mesa MO (January 2020). "B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin". CNS Neurosci Ther. 26 (1): 5–13. doi:10.1111/cns.13207. PMC 6930825. PMID 31490017.
5. Smith AG (2019-09-21). "Plants need their vitamins too". Current Opinion in Plant Biology. 10 (3): 266–275. doi:10.1016/j.pbi.2007.04.009. PMID 17434786.
6. "Vitamin B₁₂". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis, OR. 4 June 2015. from the original on 29 October 2019. Retrieved 5 April 2019.
7. Vincenti A, Bertuzzo L, Limitone A, D'Antona G, Cena H (June 2021). "Perspective: Practical Approach to Preventing Subclinical B12 Deficiency in Elderly Population". Nutrients. 13 (6): 1913. doi:10.3390/nu13061913. PMC 8226782. PMID 34199569.
8. Watanabe F, Bito T (January 2018). "Vitamin B12 sources and microbial interaction". Exp Biol Med (Maywood). 243 (2): 148–158. doi:10.1177/1535370217746612. PMC 5788147. PMID 29216732.
9. Stabler SP (2020). "Vitamin B12". In BP Marriott, DF Birt, VA Stallings, AA Yates (eds.). Present Knowledge in Nutrition, Eleventh Edition. London: Academic Press (Elsevier). pp. 257–272. ISBN 978-0-323-66162-1. US survey data from the NHANES What We Eat in America 2013e16 cohort reported the median vitamin B12 consumption for all adult men of 5.1 mcg and women of 3.5 mcg.95b Using the Estimated Average Requirement (EAR) for adults for Vitamin B12 of 2 mcg,93 less than 3% of men and 8% of women in the United States had inadequate diets using this comparator. However, 11% of girls 14e18 years had intakes less than their EAR of 2.0 mcg.
10. Institute of Medicine (1998). "Vitamin B₁₂". Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B₆, Folate, Vitamin B₁₂, Pantothenic Acid, Biotin, and Choline. Washington, DC: The National Academies Press. pp. 306–356. ISBN 978-0-309-06554-2. Retrieved February 7, 2012.
11. "Acid-Reflux Drugs Tied to Lower Levels of Vitamin B-12". WebMD. from the original on 2018-07-23. Retrieved 2018-07-23.
12. "Vitamin B12 Deficiency Anemia". www.hopkinsmedicine.org. 8 August 2021. Retrieved 2022-02-16.
13. "Pernicious anemia: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2022-01-06.
14. Baik HW, Russell RM (2021-11-18). "Vitamin B12 deficiency in the elderly". Annual Review of Nutrition. 19: 357–377. doi:10.1146/annurev.nutr.19.1.357. PMID 10448529.
15. Butler P, Kräutler B (2006). "Biological Organometallic Chemistry of B12". Bioorganometallic Chemistry. Topics in Organometallic Chemistry. Vol. 17. pp. 1–55. doi:10.1007/3418_004. ISBN 3-540-33047-X.
16. Banerjee R, Ragsdale SW (July 2003). "The many faces of vitamin B12: catalysis by cobalamin-dependent enzymes". Annual Review of Biochemistry. 72: 209–247. doi:10.1146/annurev.biochem.72.121801.161828. PMID 14527323. S2CID 37393683.
17. Obeid R, Fedosov SN, Nexo E (July 2015). "Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency". Molecular Nutrition & Food Research. 59 (7): 1364–1372. doi:10.1002/mnfr.201500019. PMC 4692085. PMID 25820384.
18. Paul C, Brady DM (February 2017). "Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms". Integr Med (Encinitas). 16 (1): 42–49. PMC 5312744. PMID 28223907.
19. Watanabe F, Bito T (September 2018). "Determination of Cobalamin and Related Compounds in Foods". J AOAC Int. 101 (5): 1308–1313. doi:10.5740/jaoacint.18-0045. PMID 29669618. S2CID 4978703.
20. Watanabe F, Katsura H, Takenaka S, Fujita T, Abe K, Tamura Y, Nakatsuka T, Nakano Y (November 1999). "Pseudovitamin B(12) is the predominant cobamide of an algal health food, spirulina tablets". J. Agric. Food Chem. 47 (11): 4736–4741. doi:10.1021/jf990541b. PMID 10552882.
21. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ (April 2001). "Folate, homocysteine and neural tube defects: an overview". Experimental Biology and Medicine. 226 (4): 243–270. doi:10.1177/153537020122600402. PMID 11368417. S2CID 29053617.
22. Skerrett PJ (February 2019). "Vitamin B12 deficiency can be sneaky, harmful". Harvard Health Blog. from the original on 29 October 2019. Retrieved 6 January 2020.
23. "Vitamin B₁₂ or folate deficiency anaemia – Symptoms". National Health Service, England. 23 May 2019. from the original on 12 August 2017. Retrieved 6 January 2020.
24. Masalha R, Chudakov B, Muhamad M, Rudoy I, Volkov I, Wirguin I (September 2001). "Cobalamin-responsive psychosis as the sole manifestation of vitamin B12 deficiency". The Israel Medical Association Journal. 3 (9): 701–703. PMID 11574992.
25. Lachner C, Steinle NI, Regenold WT (2012). "The neuropsychiatry of vitamin B12 deficiency in elderly patients". J Neuropsychiatry Clin Neurosci. 24 (1): 5–15. doi:10.1176/appi.neuropsych.11020052. PMID 22450609. S2CID 20350330.
26. Bennett M (March 2001). "Vitamin B12 deficiency, infertility and recurrent fetal loss". The Journal of Reproductive Medicine. 46 (3): 209–212. PMID 11304860.
27. "What Is Pernicious Anemia?". NHLBI. April 1, 2011. from the original on 14 March 2016. Retrieved 14 March 2016.
28. Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, Adami F (November 2013). "Cobalamin Deficiency: Clinical Picture and Radiological Findings". Nutrients. 5 (11): 4521–4539. doi:10.3390/nu5114521. ISSN 2072-6643. PMC 3847746. PMID 24248213.
29. Amarapurka DN, Patel ND (September 2004). "Gastric Antral Vascular Ectasia (GAVE) Syndrome" (PDF). Journal of the Association of Physicians of India. 52: 757. (PDF) from the original on 2016-03-04.
30. Greenburg M (2010). Handbook of Neurosurgery 7th Edition. New York: Thieme Publishers. pp. 1187–1188. ISBN 978-1-60406-326-4.
31. Lerner NB (2016). "Vitamin B12 Deficiency". In Kliegman RM, Stanton B, St Geme J, Schor NF (eds.). Nelson Textbook of Pediatrics (20th ed.). pp. 2319–2326. ISBN 978-1-4557-7566-8.
32. Melina V, Craig W, Levin S (2016). "Position of the Academy of Nutrition and Dietetics: Vegetarian Diets". J Acad Nutr Diet. 116 (12): 1970–1980. doi:10.1016/j.jand.2016.09.025. PMID 27886704. Fermented foods (such as tempeh), nori, spirulina, chlorella algae, and unfortified nutritional yeast cannot be relied upon as adequate or practical sources of B-12.39,40 Vegans must regularly consume reliable sources—meaning B-12 fortified foods or B-12 containing supplements—or they could become deficient, as shown in case studies of vegan infants, children, and adults.
33. Pawlak R, Parrott SJ, Raj S, Cullum-Dugan D, Lucus D (February 2013). "How prevalent is vitamin B(12) deficiency among vegetarians?". Nutrition Reviews. 71 (2): 110–117. doi:10.1111/nure.12001. PMID 23356638.
34. Woo KS, Kwok TC, Celermajer DS (August 2014). "Vegan diet, subnormal vitamin B-12 status and cardiovascular health". Nutrients. 6 (8): 3259–3273. doi:10.3390/nu6083259. PMC 4145307. PMID 25195560.
35. Obeid R, Murphy M, Solé-Navais P, Yajnik C (November 2017). "Cobalamin Status from Pregnancy to Early Childhood: Lessons from Global Experience". Adv Nutr. 8 (6): 971–979. doi:10.3945/an.117.015628. PMC 5683008. PMID 29141978.
36. "Overview on Dietary Reference Values for the EU population as derived by the EFSA Panel on Dietetic Products, Nutrition and Allergies" (PDF). 2017. (PDF) from the original on 2020-01-07. Retrieved 2017-08-28.
37. Rogne T, Tielemans MJ, Chong MF, Yajnik CS, Krishnaveni GV, Poston L, et al. (February 2017). "Associations of Maternal Vitamin B12 Concentration in Pregnancy With the Risks of Preterm Birth and Low Birth Weight: A Systematic Review and Meta-Analysis of Individual Participant Data". Am J Epidemiol. 185 (3): 212–223. doi:10.1093/aje/kww212. PMC 5390862. PMID 28108470.
38. Sebastiani G, Herranz Barbero A, Borrás-Novell C, Alsina Casanova M, Aldecoa-Bilbao V, Andreu-Fernández V, Pascual Tutusaus M, Ferrero Martínez S, Gómez Roig MD, García-Algar O (March 2019). "The Effects of Vegetarian and Vegan Diet during Pregnancy on the Health of Mothers and Offspring". Nutrients. 11 (3): 557. doi:10.3390/nu11030557. PMC 6470702. PMID 30845641.
39. "Map: Count of Nutrients In Fortification Standards". Global Fortification Data Exchange. from the original on 11 April 2019. Retrieved 15 April 2020.
40. Weng TC, Chang CH, Dong YH, Chang YC, Chuang LM (July 2015). "Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis". BMJ Open. 5 (7): e006964. doi:10.1136/bmjopen-2014-006964. PMC 4513480. PMID 26185175.
41. Majumder S, Soriano J, Louie Cruz A, Dasanu CA (2013). "Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations". Surg Obes Relat Dis. 9 (6): 1013–1019. doi:10.1016/j.soard.2013.04.017. PMID 24091055.
42. Mahawar KK, Reid A, Graham Y, Callejas-Diaz L, Parmar C, Carr WR, Jennings N, Singhal R, Small PK (July 2018). "Oral Vitamin B12 Supplementation After Roux-en-Y Gastric Bypass: a Systematic Review". Obes Surg. 28 (7): 1916–1923. doi:10.1007/s11695-017-3102-y. PMID 29318504. S2CID 35209784.
43. Shipton MJ, Thachil J (April 2015). "Vitamin B12 deficiency – A 21st century perspective". Clin Med (Lond). 15 (2): 145–150. doi:10.7861/clinmedicine.15-2-145. PMC 4953733. PMID 25824066.
44. Moretti R, Caruso P (January 2019). "The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice". Int J Mol Sci. 20 (1): 231. doi:10.3390/ijms20010231. PMC 6337226. PMID 30626145.
45. "Methylmalonic acidemia". Genetics Home Reference. US National Library of Medecine. October 2015. Retrieved 10 July 2022.
46. Devalia V (Aug 2006). "Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay". BMJ. 333 (7564): 385–386. doi:10.1136/bmj.333.7564.385. PMC 1550477. PMID 16916826.
47. Devalia V, Hamilton MS, Molloy AM (August 2014). "Guidelines for the diagnosis and treatment of cobalamin and folate disorders". Br. J. Haematol. 166 (4): 496–513. doi:10.1111/bjh.12959. PMID 24942828. S2CID 5772424.
48. Hall AH, Rumack BH (1987). "Hydroxycobalamin/sodium thiosulfate as a cyanide antidote". The Journal of Emergency Medicine. 5 (2): 115–121. doi:10.1016/0736-4679(87)90074-6. PMID 3295013.
49. MacLennan L, Moiemen N (February 2015). "Management of cyanide toxicity in patients with burns". Burns. 41 (1): 18–24. doi:10.1016/j.burns.2014.06.001. PMID 24994676.
50. Dart RC (2006). "Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting". Clinical Toxicology. 44 (Suppl. 1): 1–3. doi:10.1080/15563650600811607. PMID 16990188.
51. "Foods highest in Vitamin B₁₂ (based on levels per 100-gram serving)". Nutrition Data. Condé Nast, USDA National Nutrient Database, release SR-21. 2014. from the original on November 16, 2019. Retrieved February 16, 2017.
52. "Tolerable Upper Intake Levels For Vitamins And Minerals" (PDF). European Food Safety Authority. 2006. (PDF) from the original on 2019-10-15. Retrieved 2016-03-12.
53. "Dietary Reference Intakes for Japanese 2010: Water-Soluble Vitamins" Journal of Nutritional Science and Vitaminology 2013(59):S67–S82.
54. World Health Organization (2005). "Chapter 14: Vitamin B12". Vitamin and Mineral Requirements in Human Nutrition (2nd ed.). Geneva: World Health Organization. pp. 279–287. hdl:10665/42716. ISBN 978-92-4-154612-6.
55. "Food Labeling: Revision of the Nutrition and Supplement Facts Labels" (PDF). Federal Register. May 27, 2016. p. 33982. (PDF) from the original on August 8, 2016. Retrieved August 27, 2017.
56. . Dietary Supplement Label Database (DSLD). Archived from the original on 7 April 2020. Retrieved 16 May 2020.
57. "Changes to the Nutrition Facts Label". U.S. Food and Drug Administration (FDA). 27 May 2016. Retrieved 16 May 2020.   This article incorporates text from this source, which is in the public domain.
58. "Industry Resources on the Changes to the Nutrition Facts Label". U.S. Food and Drug Administration (FDA). 21 December 2018. Retrieved 16 May 2020.   This article incorporates text from this source, which is in the public domain.
59. Fang H, Kang J, Zhang D (January 2017). "Microbial production of vitamin B12: a review and future perspectives". Microbial Cell Factories. 16 (1): 15. doi:10.1186/s12934-017-0631-y. PMC 5282855. PMID 28137297.
60. Moore SJ, Warren MJ (June 2012). "The anaerobic biosynthesis of vitamin B12". Biochemical Society Transactions. 40 (3): 581–586. doi:10.1042/BST20120066. PMID 22616870.
61. Graham RM, Deery E, Warren MJ (2009). "18: Vitamin B₁₂: Biosynthesis of the Corrin Ring". In Warren MJ, Smith (eds.). Tetrapyrroles Birth, Life and Death. New York: Springer-Verlag. p. 286. doi:10.1007/978-0-387-78518-9_18. ISBN 978-0-387-78518-9.
62. Gille D, Schmid A (February 2015). "Vitamin B12 in meat and dairy products". Nutrition Reviews. 73 (2): 106–115. doi:10.1093/nutrit/nuu011. PMID 26024497.
63. Stevens CE, Hume ID (April 1998). "Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients". Physiol. Rev. 78 (2): 393–427. doi:10.1152/physrev.1998.78.2.393. PMID 9562034. S2CID 103191.
64. McDowell LR (2008). Vitamins in Animal and Human Nutrition (2nd ed.). Hoboken: John Wiley & Sons. pp. 525, 539. ISBN 978-0470376683. from the original on 2017-09-08. Retrieved 2017-01-17.
65. Erickson, Anna (September 3, 2019). "Cobalt deficiency in sheep and cattle". Department of Primary Industries and Regional Development. Government of Western Australia. from the original on 2015-11-11. Retrieved 2020-04-18.
66. Rooke J (October 30, 2013). "Do carnivores need Vitamin B₁₂ supplements?". Baltimore Post Examiner. from the original on January 16, 2017. Retrieved January 17, 2017.
67. Watanabe F (November 2007). "Vitamin B12 sources and bioavailability". Experimental Biology and Medicine. 232 (10): 1266–1274. doi:10.3181/0703-MR-67. PMID 17959839. S2CID 14732788.
68. Dossey AT (February 1, 2013). "Why Insects Should Be in Your Diet". The Scientist. from the original on November 11, 2017. Retrieved April 18, 2020.
69. "Vitamin B-12 (µg)" (PDF). USDA National Nutrient Database for Standard Reference Release 28. 27 October 2015. (PDF) from the original on 26 January 2017. Retrieved 6 January 2020.
70. Liem IT, Steinkraus KH, Cronk TC (December 1977). "Production of vitamin B-12 in tempeh, a fermented soybean food". Applied and Environmental Microbiology. 34 (6): 773–776. Bibcode:1977ApEnM..34..773L. doi:10.1128/AEM.34.6.773-776.1977. PMC 242746. PMID 563702.
71. Keuth S, Bisping B (May 1994). "Vitamin B12 production by Citrobacter freundii or Klebsiella pneumoniae during tempeh fermentation and proof of enterotoxin absence by PCR". Applied and Environmental Microbiology. 60 (5): 1495–1499. Bibcode:1994ApEnM..60.1495K. doi:10.1128/AEM.60.5.1495-1499.1994. PMC 201508. PMID 8017933.
72. Mo H, Kariluoto S, Piironen V, Zhu Y, Sanders MG, Vincken JP, et al. (December 2013). "Effect of soybean processing on content and bioaccessibility of folate, vitamin B12 and isoflavones in tofu and tempe". Food Chemistry. 141 (3): 2418–2425. doi:10.1016/j.foodchem.2013.05.017. PMID 23870976.
73. Watanabe F, Yabuta Y, Bito T, Teng F (May 2014). "Vitamin B₁₂-containing plant food sources for vegetarians". Nutrients. 6 (5): 1861–1873. doi:10.3390/nu6051861. PMC 4042564. PMID 24803097.
74. Kwak CS, Lee MS, Lee HJ, Whang JY, Park SC (June 2010). "Dietary source of vitamin B(12) intake and vitamin B(12) status in female elderly Koreans aged 85 and older living in rural area". Nutrition Research and Practice. 4 (3): 229–234. doi:10.4162/nrp.2010.4.3.229. PMC 2895704. PMID 20607069.
75. Kwak CS, Lee MS, Oh SI, Park SC (2010). "Discovery of novel sources of vitamin b(12) in traditional korean foods from nutritional surveys of centenarians". Current Gerontology and Geriatrics Research. 2010: 374897. doi:10.1155/2010/374897. PMC 3062981. PMID 21436999.
76. Croft MT, Lawrence AD, Raux-Deery E, Warren MJ, Smith AG (November 2005). "Algae acquire vitamin B12 through a symbiotic relationship with bacteria". Nature. 438 (7064): 90–93. Bibcode:2005Natur.438...90C. doi:10.1038/nature04056. PMID 16267554. S2CID 4328049.
77. Kumudha A, Selvakumar S, Dilshad P, Vaidyanathan G, Thakur MS, Sarada R (March 2015). "Methylcobalamin – a form of vitamin B12 identified and characterised in Chlorella vulgaris". Food Chemistry. 170: 316–320. doi:10.1016/j.foodchem.2014.08.035. PMID 25306351.
78. Martins JH, Barg H, Warren MJ, Jahn D (March 2002). "Microbial production of vitamin B12". Appl Microbiol Biotechnol. 58 (3): 275–285. doi:10.1007/s00253-001-0902-7. PMID 11935176. S2CID 22232461.
79. Mangels R. "Vitamin B₁₂ in the Vegan Diet". Vegetarian Resource Group. from the original on December 19, 2012. Retrieved January 17, 2008.
80. "Don't Vegetarians Have Trouble Getting Enough Vitamin B₁₂?". Physicians Committee for Responsible Medicine. from the original on October 8, 2011. Retrieved January 17, 2008.
81. European Food Safety Authority (September 25, 2008). "5′-deoxyadenosylcobalamin and methylcobalamin as sources for Vitamin B₁₂ added as a nutritional substance in food supplements: Scientific opinion of the Scientific Panel on Food Additives and Nutrient Sources added to food". EFSA Journal. 815 (10): 1–21. doi:10.2903/j.efsa.2008.815. "the metabolic fate and biological distribution of methylcobalamin and 5′-deoxyadenosylcobalamin are expected to be similar to that of other sources of vitamin B₁₂ in the diet".
82. Norris J. . Vegan Health. Archived from the original on 11 May 2020. Retrieved 19 May 2020.
83. Lane LA, Rojas-Fernandez C (July–August 2002). "Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy". The Annals of Pharmacotherapy. 36 (7–8): 1268–1272. doi:10.1345/aph.1A122. PMID 12086562. S2CID 919401.
84. Butler CC, Vidal-Alaball J, Cannings-John R, McCaddon A, Hood K, Papaioannou A, Mcdowell I, Goringe A (June 2006). "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials". Family Practice. 23 (3): 279–285. doi:10.1093/fampra/cml008. PMID 16585128.
85. Arslan SA, Arslan I, Tirnaksiz F (March 2013). "Cobalamins and Methylcobalamin: Coenzyme of Vitamin B12". FABAD J. Pharm. Sci. 38 (3): 151–157. S2CID 1929961.
86. Thauvin-Robinet C, Roze E, Couvreur G, Horellou MH, Sedel F, Grabli D, Bruneteau G, Tonneti C, Masurel-Paulet A, Perennou D, Moreau T, Giroud M, de Baulny HO, Giraudier S, Faivre L (June 2008). "The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum". Journal of Neurology, Neurosurgery, and Psychiatry. 79 (6): 725–728. doi:10.1136/jnnp.2007.133025. PMID 18245139. S2CID 23493993.
87. Fidaleo M, Tacconi S, Sbarigia C, Passeri D, Rossi M, Tata AM, Dini L (March 2021). "Current Nanocarrier Strategies Improve Vitamin B12 Pharmacokinetics, Ameliorate Patients' Lives, and Reduce Costs". Nanomaterials. 11 (3): 743. doi:10.3390/nano11030743. PMC 8001893. PMID 33809596.
88. Yamada K, Yamada Y, Fukuda M, Yamada S (November 1999). "Bioavailability of Dried Asakusanori (Porphyra tenera) as a Source of Cobalamin (Vitamin B₁₂)". International Journal for Vitamin and Nutrition Research. 69 (6): 412–418. doi:10.1024/0300-9831.69.6.412. PMID 10642899.
89. Schmidt A, Call LM, Macheiner L, Mayer HK (May 2019). "Determination of vitamin B₁₂ in four edible insect species by immunoaffinity and ultra-high performance liquid chromatography". Food Chemistry. 281: 124–129. doi:10.1016/j.foodchem.2018.12.039. PMID 30658738. S2CID 58651702.
90. Yamada K, Shimodaira M, Chida S, Yamada N, Matsushima N, Fukuda M, Yamada S (2008). "Degradation of vitamin B12 in dietary supplements". International Journal for Vitamin and Nutrition Research. 78 (4–5): 195–203. doi:10.1024/0300-9831.78.45.195. PMID 19326342.
91. Kräutler B (December 2020). "Antivitamins B₁₂ -Some Inaugural Milestones". Chemistry. 26 (67): 15438–15445. doi:10.1002/chem.202003788. PMC 7756841. PMID 32956545.
92. DeVault KR, Talley NJ (September 2009). "Insights into the future of gastric acid suppression". Nat Rev Gastroenterol Hepatol. 6 (9): 524–532. doi:10.1038/nrgastro.2009.125. PMID 19713987. S2CID 25413839.
93. Ahmed MA (2016). "Metformin and Vitamin B12 Deficiency: Where Do We Stand?". Journal of Pharmacy & Pharmaceutical Sciences. 19 (3): 382–398. doi:10.18433/J3PK7P. PMID 27806244.
94. Gilligan MA (February 2002). "Metformin and vitamin B12 deficiency". Archives of Internal Medicine. 162 (4): 484–485. doi:10.1001/archinte.162.4.484. PMID 11863489.
95. Copp S (1 December 2007). . UK Medicines Information, NHS. Archived from the original on September 27, 2007.
96. "Vitamin B-12: Interactions". WebMD. Retrieved 21 April 2020.
97. Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE (February 2011). "Antiepileptic drugs interact with folate and vitamin B12 serum levels" (PDF). Ann. Neurol. 69 (2): 352–359. doi:10.1002/ana.22229. PMID 21246600. S2CID 7282489.
98. Giedyk M, Goliszewska K, Gryko D (June 2015). "Vitamin B12 catalysed reactions". Chemical Society Reviews. 44 (11): 3391–3404. doi:10.1039/C5CS00165J. PMID 25945462.
99. Jaouen G, ed. (2006). Bioorganometallics: Biomolecules, Labeling, Medicine. Weinheim: Wiley-VCH. pp. 17–25. ISBN 978-3-527-30990-0.
100. Lawrance P (March 2015). "Vitamin B12: A review of analytical methods for use in food". LGC Limited.
101. O'Leary F, Samman S (March 2010). "Vitamin B12 in Health and Disease". Nutrients. 2 (3): 299–316. doi:10.3390/nu2030299. ISSN 2072-6643. PMC 3257642. PMID 22254022.
102. Obeid R, ed. (2017-07-12). Vitamin B12. CRC Press. doi:10.1201/9781315119540. ISBN 978-1-315-11954-0.
103. Takahashi-Iñiguez T, García-Hernandez E, Arreguín-Espinosa R, Flores ME (June 2012). "Role of vitamin B12 on methylmalonyl-CoA mutase activity". J Zhejiang Univ Sci B. 13 (6): 423–437. doi:10.1631/jzus.B1100329. PMC 3370288. PMID 22661206.
104. Froese DS, Fowler B, Baumgartner MR (July 2019). "Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation". Journal of Inherited Metabolic Disease. 42 (4): 673–685. doi:10.1002/jimd.12009. PMID 30693532.
105. Reinhold A, Westermann M, Seifert J, von Bergen M, Schubert T, Diekert G (November 2012). "Impact of vitamin B12 on formation of the tetrachloroethene reductive dehalogenase in Desulfitobacterium hafniense strain Y51". Appl. Environ. Microbiol. 78 (22): 8025–8032. Bibcode:2012ApEnM..78.8025R. doi:10.1128/AEM.02173-12. PMC 3485949. PMID 22961902.
106. Payne KA, Quezada CP, Fisher K, Dunstan MS, Collins FA, Sjuts H, Levy C, Hay S, Rigby SE, Leys D (January 2015). "Reductive dehalogenase structure suggests a mechanism for B12-dependent dehalogenation". Nature. 517 (7535): 513–516. Bibcode:2015Natur.517..513P. doi:10.1038/nature13901. PMC 4968649. PMID 25327251.
107. Ballhausen D, Mittaz L, Boulat O, Bonafé L, Braissant O (December 2009). "Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain". Neuroscience. 164 (2): 578–587. doi:10.1016/j.neuroscience.2009.08.028. PMID 19699272. S2CID 34612963.
108. Marsh EN (1999). "Coenzyme B12 (cobalamin)-dependent enzymes". Essays Biochem. 34: 139–154. doi:10.1042/bse0340139. PMID 10730193.
109. Allen RH, Seetharam B, Podell E, Alpers DH (January 1978). "Effect of proteolytic enzymes on the binding of cobalamin to R protein and intrinsic factor. In vitro evidence that a failure to partially degrade R protein is responsible for cobalamin malabsorption in pancreatic insufficiency". The Journal of Clinical Investigation. 61 (1): 47–54. doi:10.1172/JCI108924. PMC 372512. PMID 22556.
110. Combs GF (2008). The vitamins: fundamental aspects in nutrition and health (3rd ed.). Amsterdam: Elsevier Academic Press. pp. 381–398. ISBN 978-0-12-183492-0. OCLC 150255807.
111. Al-Awami HM, Raja A, Soos MP (August 2019). "Physiology, Intrinsic Factor (Gastric Intrinsic Factor)". StatPearls [Internet]. PMID 31536261.
112. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J (August 1998). "Effective treatment of cobalamin deficiency with oral cobalamin". Blood. 92 (4): 1191–1198. doi:10.1182/blood.V92.4.1191. PMID 9694707.
113. "Vitamin B12 Deficiency – Nutritional Disorders". MSD Manual Professional Edition. Retrieved 2022-05-24.
114. Battersby AR, Fookes CJ, Matcham GW, McDonald E (May 1980). "Biosynthesis of the pigments of life: formation of the macrocycle". Nature. 285 (5759): 17–21. Bibcode:1980Natur.285...17B. doi:10.1038/285017a0. PMID 6769048. S2CID 9070849.
115. Frank S, Brindley AA, Deery E, Heathcote P, Lawrence AD, Leech HK, et al. (August 2005). "Anaerobic synthesis of vitamin B12: characterization of the early steps in the pathway". Biochemical Society Transactions. 33 (Pt 4): 811–814. doi:10.1042/BST0330811. PMID 16042604.
116. Battersby AR (1993). "How Nature builds the pigments of life" (PDF). Pure and Applied Chemistry. 65 (6): 1113–1122. doi:10.1351/pac199365061113. S2CID 83942303. (PDF) from the original on 2018-07-24. Retrieved 2020-02-20.
117. Battersby A (2005). "Chapter 11: Discovering the wonder of how Nature builds its molecules". In Archer MD, Haley CD (eds.). The 1702 chair of chemistry at Cambridge: transformation and change. Cambridge University Press. pp. xvi, 257–282. ISBN 0521828732.
118. Perlman D (1959). "Microbial synthesis of cobamides". Advances in Applied Microbiology. 1: 87–122. doi:10.1016/S0065-2164(08)70476-3. ISBN 9780120026012. PMID 13854292.
119. Martens JH, Barg H, Warren MJ, Jahn D (March 2002). "Microbial production of vitamin B12". Applied Microbiology and Biotechnology. 58 (3): 275–285. doi:10.1007/s00253-001-0902-7. PMID 11935176. S2CID 22232461.
120. Fang H, Kang J, Zhang D (January 2017). "Microbial production of vitamin B12: a review and future perspectives". Microb. Cell Fact. 16 (1): 15. doi:10.1186/s12934-017-0631-y. PMC 5282855. PMID 28137297.
121. Linnell JC, Matthews DM (February 1984). "Cobalamin metabolism and its clinical aspects". Clinical Science. 66 (2): 113–121. doi:10.1042/cs0660113. PMID 6420106. S2CID 27191837.
122. Piwowarek K, Lipińska E, Hać-Szymańczuk E, Kieliszek M, Ścibisz I (January 2018). "Propionibacterium spp.-source of propionic acid, vitamin B12, and other metabolites important for the industry". Appl. Microbiol. Biotechnol. 102 (2): 515–538. doi:10.1007/s00253-017-8616-7. PMC 5756557. PMID 29167919.
123. Riaz M, Ansari ZA, Iqbal F, Akram M (2007). "Microbial production of vitamin B₁₂ by methanol utilizing strain of Pseudomonas species". Pakistan Journal of Biochemistry & Molecular Biology. 1. 40: 5–10.^{[permanent dead link]}
124. Zhang Y (January 26, 2009). . China Chemical Reporter. Archived from the original on May 13, 2013.
125. Khan AG, Eswaran SV (June 2003). "Woodward's synthesis of vitamin B₁₂". Resonance. 8 (6): 8–16. doi:10.1007/BF02837864. S2CID 120110443.
126. Eschenmoser A, Wintner CE (June 1977). "Natural product synthesis and vitamin B12". Science. 196 (4297): 1410–1420. Bibcode:1977Sci...196.1410E. doi:10.1126/science.867037. PMID 867037.
127. Riether D, Mulzer J (2003). "Total Synthesis of Cobyric Acid: Historical Development and Recent Synthetic Innovations". European Journal of Organic Chemistry. 2003: 30–45. doi:10.1002/1099-0690(200301)2003:1<30::AID-EJOC30>3.0.CO;2-I.
128. "Synthesis of Cyanocobalamin by Robert B. Woodward (1973)". www.synarchive.com. from the original on 2018-02-16. Retrieved 2018-02-15.
129. Greer JP (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN 978-1-4511-7268-3. Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel
130. "George H. Whipple – Biographical". www.nobelprize.org. from the original on 2017-09-13. Retrieved 2017-10-10.
131. The Nobel Prize in Physiology or Medicine 1934 2017-10-02 at the Wayback Machine, Nobelprize.org, Nobel Media AB 2014. Retrieved December 2, 2015.
132. . Archived from the original on March 4, 2016. Retrieved March 3, 2016.
133. Shorb MS (May 10, 2012). "Annual Lecture". Department of Animal & Avian Sciences, University of Maryland. Archived from the original on December 12, 2012. Retrieved August 2, 2014.
134. Hodgkin DC, Kamper J, Mackay M, Pickworth J, Trueblood KN, White JG (July 1956). "Structure of vitamin B12". Nature. 178 (4524): 64–66. Bibcode:1956Natur.178...64H. doi:10.1038/178064a0. PMID 13348621. S2CID 4210164.
135. Dodson G (December 2002). "Dorothy Mary Crowfoot Hodgkin, 12 May 1910 – 29 July 1994". Biographical Memoirs of Fellows of the Royal Society. 48: 181–219. doi:10.1098/rsbm.2002.0011. PMID 13678070. S2CID 61764553.
136. "The Nobel Prize and the Discovery of Vitamins". www.nobelprize.org. from the original on 2018-01-16. Retrieved 2018-02-15.
137. Gaby AR (October 2002). "Intravenous nutrient therapy: the "Myers' cocktail"". Altern Med Rev. 7 (5): 389–403. PMID 12410623.
138. Gavura S (24 May 2013). "A closer look at vitamin injections". Science-Based Medicine. from the original on 11 January 2020. Retrieved 10 January 2020.
139. Bauer BA (29 March 2018). "Are vitamin B-12 injections helpful for weight loss?". Mayo Clinic. from the original on 27 November 2019. Retrieved 11 January 2020.
140. Silverstein WK, Lin Y, Dharma C, Croxford R, Earle CC, Cheung MC (July 2019). "Prevalence of Inappropriateness of Parenteral Vitamin B12 Administration in Ontario, Canada". JAMA Internal Medicine. 179 (10): 1434–1436. doi:10.1001/jamainternmed.2019.1859. ISSN 2168-6106. PMC 6632124. PMID 31305876.

External links

• Cyanocobalamin at the US National Library of Medicine Medical Subject Headings (MeSH)
• "Cyanocobalamin". Drug Information Portal. U.S. National Library of Medicine.
• "Hydroxocobalamin". Drug Information Portal. U.S. National Library of Medicine.
• "Methylcobalamin". Drug Information Portal. U.S. National Library of Medicine.
• "Adenosylcobalamin". Drug Information Portal. U.S. National Library of Medicine.